Clinical, Viral and Genetic Characteristics of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in Shanghai, China

Acta Derm Venereol. 2018 Apr 16;98(4):401-405. doi: 10.2340/00015555-2867.

Abstract

DRESS is one of the most severe drug reactions. The aim of this retrospective study was to summarize the clinical presentation, genetic predisposition and prognostic factors of DRESS. A total of 52 patients with DRESS, who were inpatients at a medical referral centre in Shanghai, China, from January 2011 to December 2016, were analysed retrospectively. All the patients had skin eruption, 83% had liver involvement, and ≤10% had other organ involvement. Mean cost of hospitalization was US$5,511±3,050. The 3 most common causative agents were allopurinol (18/52; 35%), salazosulphapyridine (11/52; 21%) and carbamazepine (5/52; 10%). HLA-B*5801 and HLA-B*1302 were associated with allopurinol-induced DRESS. HLA-B*1301 was related to salazosulphapyridine-induced DRESS. The mortality rate was 6% (3/52). Epstein-Barr virus DNA was found in 10 patients (19%) and indicated a poor prognosis. Human herpes virus 6 DNA was detected in 17 patients (33%) and was associated with autoimmune sequelae. Due to its high medical cost and sometimes poor prognosis, prevention of DRESS should be a high priority.

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adult
  • Aged
  • Aged, 80 and over
  • Allopurinol / adverse effects*
  • Carbamazepine / adverse effects*
  • China
  • DNA, Viral / genetics*
  • Drug Hypersensitivity Syndrome / drug therapy
  • Drug Hypersensitivity Syndrome / genetics*
  • Drug Hypersensitivity Syndrome / mortality
  • Drug Hypersensitivity Syndrome / virology*
  • Female
  • Genetic Predisposition to Disease
  • HLA-B Antigens / genetics*
  • HLA-DRB1 Chains / genetics
  • Herpesvirus 4, Human / genetics*
  • Herpesvirus 4, Human / pathogenicity
  • Herpesvirus 6, Human / genetics*
  • Herpesvirus 6, Human / pathogenicity
  • Hospital Costs
  • Humans
  • Immunoglobulins, Intravenous / administration & dosage
  • Length of Stay / economics
  • Male
  • Middle Aged
  • Patient Admission / economics
  • Phenotype
  • Retrospective Studies
  • Risk Factors
  • Sulfasalazine / adverse effects*
  • Time Factors
  • Virus Activation
  • Young Adult

Substances

  • Adrenal Cortex Hormones
  • DNA, Viral
  • HLA-B Antigens
  • HLA-B*58:01 antigen
  • HLA-DRB1 Chains
  • Immunoglobulins, Intravenous
  • Carbamazepine
  • Sulfasalazine
  • Allopurinol